Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Not stated	2024-05-16		NCT05866783

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cliniques universitaires Saint-Luc- Université Catholique de Louvain	66
Universitaire Ziekenhuizen KU Leuven	262
University Hospital, Antwerp	108
University Hospital, Ghent	163

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ghent University Hospital	Ghent	Belgium	57